Literature DB >> 8099992

T-cell-mediated response in Dupuytren's disease.

K S Baird1, W H Alwan, J F Crossan, B Wojciak.   

Abstract

The cause of Dupuytren's disease is unknown, but inflammatory cells might have a role. Enzymatic digestion of diseased tissue permits identification and immunofluorescent labelling of a cell subset displaying inflammatory cell morphology. Cytofluorimetry of this cell population demonstrated the presence of CD3-positive lymphocytes and expression of major histocompatibility complex (MHC) class II proteins. These results raise the possibility that Dupuytren's disease is a T-cell-mediated autoimmune disorder. The development of medical treatment on this basis may reduce the need for surgery, with its associated morbidity and high recurrence rates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099992     DOI: 10.1016/0140-6736(93)90760-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Dupuytren's contracture is associated with sprouting of substance P positive nerve fibres and infiltration by mast cells.

Authors:  T E O Schubert; C Weidler; N Borisch; C Schubert; F Hofstädter; R H Straub
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

2.  Role of the HLA System in the Pathogenesis of Dupuytren's Disease.

Authors:  Sara McCarty; Farhatullah Syed; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2010-02-09

Review 3.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Effect of Oral Prednisolone after Collagenase Injection for Dupuytren's Contracture: A Randomized, Controlled Trial with a 1-Year Follow-Up.

Authors:  Yoshihiro Abe
Journal:  J Hand Microsurg       Date:  2020-04-13

5.  Same-sex marriage, autoimmune thyroid gland dysfunction and other autoimmune diseases in Denmark 1989-2008.

Authors:  Morten Frisch; Nete Munk Nielsen; Bo Vestergaard Pedersen
Journal:  Eur J Epidemiol       Date:  2013-12-05       Impact factor: 8.082

Review 6.  Dupuytren's: a systems biology disease.

Authors:  Samrina Rehman; Royston Goodacre; Philip J Day; Ardeshir Bayat; Hans V Westerhoff
Journal:  Arthritis Res Ther       Date:  2011-09-12       Impact factor: 5.156

7.  Inflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren's Disease Fibroblasts.

Authors:  Maro Bujak; Ivana Ratkaj; Elitza Markova-Car; Davor Jurišić; Anita Horvatić; Srđan Vučinić; Jonatan Lerga; Mirela Baus-Lončar; Krešimir Pavelić; Sandra Kraljević Pavelić
Journal:  Front Mol Biosci       Date:  2015-12-08

Review 8.  Recent advances in the understanding of Dupuytren's disease.

Authors:  Thomas Layton; Jagdeep Nanchahal
Journal:  F1000Res       Date:  2019-02-28

Review 9.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

Review 10.  Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.

Authors:  Franz Rödel; Claudia Fournier; Julia Wiedemann; Felicitas Merz; Udo S Gaipl; Benjamin Frey; Ludwig Keilholz; M Heinrich Seegenschmiedt; Claus Rödel; Stephanie Hehlgans
Journal:  Front Immunol       Date:  2017-05-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.